NEW YORK, April 25, 2017 /PRNewswire/ -- The Global CRO
Market, Forecast to 2021, presents an overview and analysis of the
global clinical trials and research outsourcing (CRO) market. It
provides revenue forecasts for CROs globally by phase, therapeutic
type and region. With the consolidation of the market as well as a
higher cost and risk involved, the big companies are slowly
shifting their business models towards a more collaborative
business model and have started to look out for partners, giving
rise to Bio analytics focused CROs.
Read the full report:
http://www.reportlinker.com/p04847400/Global-CRO-Market.html
The research study also addresses some of the major issues and
challenges alongside providing information on the key unmet needs
and emerging trends in the market. The report also outlines market
drivers and restraints, market engineering measurements as well as
R&D trends.
Alongside the challenges and opportunities, a special focus is
given on the emerging trends and their importance across the
current and future market scenario. The report also highlights some
of the major shifts occurring in the CRO and Pharma ecosystem with
the emergence of several new and innovative CRO players in the
market with a specific focus on niche segments, such as
bioanalytics and HEOR amongst others.
Further to this, a detailed information will be provided on support
services such as Central laboratory services, Bio analytics and
Data management. The report covers the complete life cycle of CRO
industry, starting from preclinical trials to post-marketing
surveillance. One of the focus areas of this study would be bio
analytics services, which is making a big impact in CRO industry.
There is a major shift observed across the CRO landscape with
several key pharma players now outsourcing their early drug
development activities (pre-clinical and early phase research) to
some of the leading CRO players in the market which was earlier
handled by pharma companies themselves.
Some of the key questions being answered by this report
include:
• How will the contract research outsourcing help in drug
development by saving time and cost for manufacturers?
• What is the impact of the market growth in different regions?
• Who are the dominant market participants in the CRO market and
their market share contribution?
• What are the key market trends observed toward expansion of
contract research organizations in drug development across key
therapeutic areas?
• Do the products/services offered today meet customer needs or is
additional development needed?
• What are the key segments to look out for and what are the key
trends in the market?
Read the full report:
http://www.reportlinker.com/p04847400/Global-CRO-Market.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/global-cro-market-to-reach-6458-billion-by-2021-300445829.html
SOURCE Reportlinker